Susanna Davis Howard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Susanna Davis Howard has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Iahn Cajigas
Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, USA
5 shared publications - Ellie D. Gabriel
University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
4 shared publications Casey H. Halpern
Department of Neurosurgery Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA
3 shared publications- John T. Farrar
Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, United States
3 shared publications - Shikha Singh
University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
3 shared publications - Whitley W. Aamodt
Department of Neurology, University of Pennsylvania, Philadelphia
3 shared publications
Latest Publications
- Open Access
- 4 March 2026
- Published by Wiley in Movement Disorders
- Vol. 41 (6) , 1337-1348
When the Scale Drops: Pathways to Weight Loss in Parkinson's Disease and Future Directions
Although Parkinson's disease (PD) is classically defined by its motor features, non‐motor symptoms exert a substantial and often under‐recognized influence on disease trajectory. Among these, weight loss has long been observed in PD and other neurodegenerative disorders, yet the mechanisms remain incompletely understood. This limited mechanistic insight has left few treatment options for weight loss in PD. Emerging research highlights the role of metabolic regulation, neuroendocrine signaling, pharmacologic treatment, cognitive decline, gastrointestinal dysfunction, and brain stimulation in shaping weight trajectories in PD. In this review, we synthesize current evidence surrounding weight in PD, beginning with an overview of epidemiologic trends and their implications for morbidity and mortality. The sections that follow examine proposed mechanisms, clinical and treatment‐related factors associated with weight change, and insights derived from deep brain stimulation studies. Finally, we summarize cross‐mechanism interactions, current knowledge gaps and discuss practical recommendations for translating these insights into therapeutic strategies. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- 4 March 2026
- Published by Wiley in Movement Disorders
- Vol. 41 (6) , 1337-1348
Open AccessWhen the Scale Drops: Pathways to Weight Loss in Parkinson's Disease and Future Directions
Although Parkinson's disease (PD) is classically defined by its motor features, non‐motor symptoms exert a substantial and often under‐recognized influence on disease trajectory. Among these, weight loss has long been observed in PD and other neurodegenerative disorders, yet the mechanisms remain incompletely understood. This limited mechanistic insight has left few treatment options for weight loss in PD. Emerging research highlights the role of metabolic regulation, neuroendocrine signaling, pharmacologic treatment, cognitive decline, gastrointestinal dysfunction, and brain stimulation in shaping weight trajectories in PD. In this review, we synthesize current evidence surrounding weight in PD, beginning with an overview of epidemiologic trends and their implications for morbidity and mortality. The sections that follow examine proposed mechanisms, clinical and treatment‐related factors associated with weight change, and insights derived from deep brain stimulation studies. Finally, we summarize cross‐mechanism interactions, current knowledge gaps and discuss practical recommendations for translating these insights into therapeutic strategies. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- Open Access
- 14 October 2025
- Published by Frontiers Media SA in Frontiers in Human Neuroscience
- Vol. 19, 1570555
Emerging neuromodulation treatments for opioid and stimulant use disorders
Over the past decade, deaths attributable to opioid and stimulant use have risen dramatically. While the U.S. Food and Drug Administration (FDA) has approved three medications for opioid use disorder, there is currently no FDA-approved treatment for stimulant use disorder. Despite the availability of medications for opioid use disorder, the rates of relapse and overdose, particularly in the time of widespread fentanyl use, remain distressingly high. There is an urgent need for more effective treatment options for these debilitating disorders. This article provides an overview of the current standard of care for opioid use disorder and stimulant use disorder. New and emerging neuromodulation approaches with a particular focus on deep brain stimulation are then discussed.
- 14 October 2025
- Published by Frontiers Media SA in Frontiers in Human Neuroscience
- Vol. 19, 1570555
Open AccessEmerging neuromodulation treatments for opioid and stimulant use disorders
Over the past decade, deaths attributable to opioid and stimulant use have risen dramatically. While the U.S. Food and Drug Administration (FDA) has approved three medications for opioid use disorder, there is currently no FDA-approved treatment for stimulant use disorder. Despite the availability of medications for opioid use disorder, the rates of relapse and overdose, particularly in the time of widespread fentanyl use, remain distressingly high. There is an urgent need for more effective treatment options for these debilitating disorders. This article provides an overview of the current standard of care for opioid use disorder and stimulant use disorder. New and emerging neuromodulation approaches with a particular focus on deep brain stimulation are then discussed.
- Open Access
- 12 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6438
Short-Term Differences in Hospital Resource Utilization and Quality of Care Between Anterior Cervical Discectomy and Fusion and Posterior Cervical Foraminotomy: A National Propensity-Scored Observational Study Utilizing the ACS-NSQIP Database
Background/Objective: Anterior cervical discectomy and fusion (ACDF) or posterior cervical foraminotomy (PCF) are common treatments for cervical radiculopathy. This study compared post-operative outcomes between ACDF and PCF utilizing the American College of Surgeons-National Surgical Quality Improvement Program database. Methods: An observational study following STROBE and TRIPOD + AI guidelines compared hospital resource utilization and quality of care between single-level ACDF and PCF (2005–2022). Primary outcomes compared operative time, length of stay (LOS), and post-operative complications. Propensity-scored stabilized inverse probability of treatment weighting adjusted for confounders, specifically demographics, lifestyle-related factors, pre-operative labs, pre-existing comorbidities, and surgery-related factors. Subgroup analysis compared baseline characteristics and outcomes, stratified by 30-day re-admission and re-operation. Results: PCF group demonstrated shorter LOS (MD −0.7 days, 95% CI −0.9 to −0.5 days, p < 0.001), operative time (MD −32.9 min, 95% CI −35.7 to −30.1 min, p < 0.001), higher rate of re-admission associated with overall SSI (PD 1.2%, 95% CI 0.7–1.7%, p < 0.001), deep incisional SSI (PD 0.8%, 95% CI 0.4–1.2%, p < 0.001), and organ/space SSI (PD 0.3%, 95% CI 0.0–0.5%, p = 0.011). Furthermore, the PCF group had greater systemic sepsis (PD 0.8%, 95% CI 0.4–1.3%, p < 0.001), overall post-operative SSI (PD 2.8%, 95% CI 2.0–3.6%, p < 0.001), superficial SSI (PD 1.9%, 95% CI 1.2–2.5%, p < 0.001), and deep incisional SSI (PD 0.8%, 95% CI 0.4–1.2%, p < 0.001) rates. Subgroup analysis showed increased early post-operative re-operation rates in the PCF cohort (PD 23.4%, 95% CI 9.5–37.4%, p = 0.001) and increased early post-operative re-admission associated with post-operative overall SSI (PD 35.3%, 95% CI 22.7–48.0%, p < 0.001). Conclusions: Although the PCF cohort demonstrated lower hospital utilization, it had reduced quality of care and increased post-operative complications.
- 12 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6438
Open AccessShort-Term Differences in Hospital Resource Utilization and Quality of Care Between Anterior Cervical Discectomy and Fusion and Posterior Cervical Foraminotomy: A National Propensity-Scored Observational Study Utilizing the ACS-NSQIP Database
Background/Objective: Anterior cervical discectomy and fusion (ACDF) or posterior cervical foraminotomy (PCF) are common treatments for cervical radiculopathy. This study compared post-operative outcomes between ACDF and PCF utilizing the American College of Surgeons-National Surgical Quality Improvement Program database. Methods: An observational study following STROBE and TRIPOD + AI guidelines compared hospital resource utilization and quality of care between single-level ACDF and PCF (2005–2022). Primary outcomes compared operative time, length of stay (LOS), and post-operative complications. Propensity-scored stabilized inverse probability of treatment weighting adjusted for confounders, specifically demographics, lifestyle-related factors, pre-operative labs, pre-existing comorbidities, and surgery-related factors. Subgroup analysis compared baseline characteristics and outcomes, stratified by 30-day re-admission and re-operation. Results: PCF group demonstrated shorter LOS (MD −0.7 days, 95% CI −0.9 to −0.5 days, p < 0.001), operative time (MD −32.9 min, 95% CI −35.7 to −30.1 min, p < 0.001), higher rate of re-admission associated with overall SSI (PD 1.2%, 95% CI 0.7–1.7%, p < 0.001), deep incisional SSI (PD 0.8%, 95% CI 0.4–1.2%, p < 0.001), and organ/space SSI (PD 0.3%, 95% CI 0.0–0.5%, p = 0.011). Furthermore, the PCF group had greater systemic sepsis (PD 0.8%, 95% CI 0.4–1.3%, p < 0.001), overall post-operative SSI (PD 2.8%, 95% CI 2.0–3.6%, p < 0.001), superficial SSI (PD 1.9%, 95% CI 1.2–2.5%, p < 0.001), and deep incisional SSI (PD 0.8%, 95% CI 0.4–1.2%, p < 0.001) rates. Subgroup analysis showed increased early post-operative re-operation rates in the PCF cohort (PD 23.4%, 95% CI 9.5–37.4%, p = 0.001) and increased early post-operative re-admission associated with post-operative overall SSI (PD 35.3%, 95% CI 22.7–48.0%, p < 0.001). Conclusions: Although the PCF cohort demonstrated lower hospital utilization, it had reduced quality of care and increased post-operative complications.
- Open Access
- 11 August 2025
- Published by Elsevier in World Neurosurgery: X
- Vol. 28
Perception of neurosurgery among surgical patients with essential tremor: A qualitative mixed methods study
- 11 August 2025
- Published by Elsevier in World Neurosurgery: X
- Vol. 28
Open AccessPerception of neurosurgery among surgical patients with essential tremor: A qualitative mixed methods study
- 1 July 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 256, 109034
The association between prehabilitation participation and spine surgery outcomes
- 1 July 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 256, 109034
The association between prehabilitation participation and spine surgery outcomes
- 11 May 2025
- Published by Taylor & Francis in Brain Injury
- Vol. 39 (11) , 963-969
A prediction model of adenosine diphosphate inhibition among traumatic brain injury patients
Coagulopathy in the setting of traumatic brain injury (TBI) increases the risk of poor outcomes. Thromboelastography with platelet mapping (TEG-PM) provides a dynamic assessment of clotting parameters including adenosine diphosphate (ADP) inhibition and can guide antiplatelet reversal. A cross-sectional study of a single Level I Trauma Center traumatic brain injury database from February 2015 to March 2024 was conducted to develop a prediction model of ADP inhibition. Included patients had evidence of traumatic intracranial hemorrhage on CT at the time of presentation and underwent TEG-PM testing. Patients with a history of antiplatelet or anticoagulant use were excluded. Significant ADP inhibition was defined as ≥ 60%. 485 patients were included. Patients with significant ADP inhibition were younger and more likely to have a severe head injury (Glasgow Coma Scale 3-8). In a multivariate logistic regression model including age and head injury severity as independent variables, severe head injury significantly increased the likelihood of ADP inhibition (odds ratio 2.14, 95% confidence interval 1.28-3.58). The observation that severe head injury was significantly associated with ADP inhibition could help identify patients at risk for platelet dysfunction in settings without TEG-PM.
- 11 May 2025
- Published by Taylor & Francis in Brain Injury
- Vol. 39 (11) , 963-969
A prediction model of adenosine diphosphate inhibition among traumatic brain injury patients
Coagulopathy in the setting of traumatic brain injury (TBI) increases the risk of poor outcomes. Thromboelastography with platelet mapping (TEG-PM) provides a dynamic assessment of clotting parameters including adenosine diphosphate (ADP) inhibition and can guide antiplatelet reversal. A cross-sectional study of a single Level I Trauma Center traumatic brain injury database from February 2015 to March 2024 was conducted to develop a prediction model of ADP inhibition. Included patients had evidence of traumatic intracranial hemorrhage on CT at the time of presentation and underwent TEG-PM testing. Patients with a history of antiplatelet or anticoagulant use were excluded. Significant ADP inhibition was defined as ≥ 60%. 485 patients were included. Patients with significant ADP inhibition were younger and more likely to have a severe head injury (Glasgow Coma Scale 3-8). In a multivariate logistic regression model including age and head injury severity as independent variables, severe head injury significantly increased the likelihood of ADP inhibition (odds ratio 2.14, 95% confidence interval 1.28-3.58). The observation that severe head injury was significantly associated with ADP inhibition could help identify patients at risk for platelet dysfunction in settings without TEG-PM.
- 28 March 2025
- Published by Wolters Kluwer Health in Clinical Spine Surgery
- Vol. 39 (1) , E32-E37
Accuracy of RAPT Score in Predicting Discharge Disposition in Patients Undergoing Spine Surgery Within an Enhanced Recovery After Surgery Program
Study Design: This is a retrospective cohort study. Objective: The primary objective was to determine the accuracy of the Risk Assessment and Prediction Tool (RAPT) score-based discharge disposition prediction among patients undergoing spine surgery within an Enha Recovery After Surgery (ERAS) program. The secondary objective was to determine if using RAPT to initiate preoperative referrals to home services expedited care. Summary of Background Data: The RAPT score has been applied to spine surgery patients but has not been validated among participants in an ERAS program. Methods: All patients undergoing elective spine surgery within an ERAS program over a 1-year period received a preoperative social work evaluation incorporating the generation of RAPT score. Patients predicted to be discharged home with services received a preoperative referral for home services. The predicted versus actual discharge destination was compared, and the association of preoperative home services referral with the timing of home services initiation was assessed. Results: Four hundred eight patients received a preoperative social work evaluation with RAPT score calculation. Two hundred seven (50.7%) patients had an accurately predicted postoperative discharge disposition based on RAPT score. Among the patients who received home services following discharge, the mean time to receipt of home services was shorter among patients who had a correct discharge disposition prediction compared with patients who had an incorrect prediction, but this difference was not statistically significant [31.3 (SD: 15.6) vs. 42.0 h (SD: 44.2), P =0.24]. Conclusions: This study supports the feasibility of integrating RAPT score calculation into a preoperative social work evaluation. However, the traditional tiers of RAPT scores had limited accuracy in predicting discharge disposition in this cohort of patients undergoing spine surgery within an ERAS program. Level of Evidence: Level III.
- 28 March 2025
- Published by Wolters Kluwer Health in Clinical Spine Surgery
- Vol. 39 (1) , E32-E37
Accuracy of RAPT Score in Predicting Discharge Disposition in Patients Undergoing Spine Surgery Within an Enhanced Recovery After Surgery Program
Study Design: This is a retrospective cohort study. Objective: The primary objective was to determine the accuracy of the Risk Assessment and Prediction Tool (RAPT) score-based discharge disposition prediction among patients undergoing spine surgery within an Enha Recovery After Surgery (ERAS) program. The secondary objective was to determine if using RAPT to initiate preoperative referrals to home services expedited care. Summary of Background Data: The RAPT score has been applied to spine surgery patients but has not been validated among participants in an ERAS program. Methods: All patients undergoing elective spine surgery within an ERAS program over a 1-year period received a preoperative social work evaluation incorporating the generation of RAPT score. Patients predicted to be discharged home with services received a preoperative referral for home services. The predicted versus actual discharge destination was compared, and the association of preoperative home services referral with the timing of home services initiation was assessed. Results: Four hundred eight patients received a preoperative social work evaluation with RAPT score calculation. Two hundred seven (50.7%) patients had an accurately predicted postoperative discharge disposition based on RAPT score. Among the patients who received home services following discharge, the mean time to receipt of home services was shorter among patients who had a correct discharge disposition prediction compared with patients who had an incorrect prediction, but this difference was not statistically significant [31.3 (SD: 15.6) vs. 42.0 h (SD: 44.2), P =0.24]. Conclusions: This study supports the feasibility of integrating RAPT score calculation into a preoperative social work evaluation. However, the traditional tiers of RAPT scores had limited accuracy in predicting discharge disposition in this cohort of patients undergoing spine surgery within an ERAS program. Level of Evidence: Level III.
- 23 March 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 252, 108860
The social deprivation index and deep brain stimulation: A cohort study
- 23 March 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 252, 108860
The social deprivation index and deep brain stimulation: A cohort study
- 25 December 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 249, 108710
Correlation of the clinical rating scale for tremor with a global assessment
- 25 December 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 249, 108710
Correlation of the clinical rating scale for tremor with a global assessment
- Open Access
- 23 September 2024
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 14 (1) , 47
Reasons for Hospitalizations and Emergency Department Visits Among Patients with Essential Tremor
Background: Prior studies suggest that patients with essential tremor (ET) have increased rates of healthcare utilization, but the reason for this increased use is unknown. The objective of this study was to evaluate the reasons for healthcare use among ET patients. Methods: This was a retrospective cross-sectional study of ET patients with an admission or emergency department (ED) visit at a tertiary health system from 2018–2023. Patients were matched on an encounter level with control patients based on propensity scores incorporating age, sex, race, and co-morbid conditions. The primary outcome was the odds of an encounter for each diagnostic category comparing ET patients with matched controls. Results: Only inpatient admissions for neurologic diagnoses were more likely for ET compared to control patients (odds ratio (OR) 3.73, 95% confidence interval (CI) 2.54 – 5.49, p < 0.001). Once admissions related to the surgical treatment of tremor were excluded, admissions for neurologic diagnoses were equally likely among ET and control patients (OR 0.96, 95% CI 0.59 – 1.57, p = 0.88). Discussion: Surgical treatment of tremor appears to be a key driver of healthcare use among ET patients. Future investigations should examine the pattern of healthcare use of ET patients before and after surgery. Highlights Prior studies have shown increased healthcare use among essential tremor (ET) patients. The objective of this study was to evaluate the reasons for healthcare use among ET patients compared to matched control patients. Surgical treatment of tremor was found to be a key driver of healthcare use among ET patients.
- 23 September 2024
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 14 (1) , 47
Open AccessReasons for Hospitalizations and Emergency Department Visits Among Patients with Essential Tremor
Background: Prior studies suggest that patients with essential tremor (ET) have increased rates of healthcare utilization, but the reason for this increased use is unknown. The objective of this study was to evaluate the reasons for healthcare use among ET patients. Methods: This was a retrospective cross-sectional study of ET patients with an admission or emergency department (ED) visit at a tertiary health system from 2018–2023. Patients were matched on an encounter level with control patients based on propensity scores incorporating age, sex, race, and co-morbid conditions. The primary outcome was the odds of an encounter for each diagnostic category comparing ET patients with matched controls. Results: Only inpatient admissions for neurologic diagnoses were more likely for ET compared to control patients (odds ratio (OR) 3.73, 95% confidence interval (CI) 2.54 – 5.49, p < 0.001). Once admissions related to the surgical treatment of tremor were excluded, admissions for neurologic diagnoses were equally likely among ET and control patients (OR 0.96, 95% CI 0.59 – 1.57, p = 0.88). Discussion: Surgical treatment of tremor appears to be a key driver of healthcare use among ET patients. Future investigations should examine the pattern of healthcare use of ET patients before and after surgery. Highlights Prior studies have shown increased healthcare use among essential tremor (ET) patients. The objective of this study was to evaluate the reasons for healthcare use among ET patients compared to matched control patients. Surgical treatment of tremor was found to be a key driver of healthcare use among ET patients.